157 related articles for article (PubMed ID: 23408495)
1. Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.
Ahmed GF; Brundage RC; Marino SE; Cloyd JC; Leppik IE; Pennell PB; Ramsay RE; Birnbaum AK
J Clin Pharmacol; 2013 Mar; 53(3):276-84. PubMed ID: 23408495
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
3. Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.
Marino SE; Birnbaum AK; Leppik IE; Conway JM; Musib LC; Brundage RC; Ramsay RE; Pennell PB; White JR; Gross CR; Rarick JO; Mishra U; Cloyd JC
Clin Pharmacol Ther; 2012 Mar; 91(3):483-8. PubMed ID: 22278332
[TBL] [Abstract][Full Text] [Related]
4. Iron supplements in nursing home patients associated with reduced carbamazepine absorption.
Ahn JE; Bathena SPR; Brundage RC; Conway JM; Leppik IE; Birnbaum AK
Epilepsy Res; 2018 Nov; 147():115-118. PubMed ID: 30327119
[TBL] [Abstract][Full Text] [Related]
5. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
6. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
Kong ST; Lim SH; Chan E; Ho PC
J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
[TBL] [Abstract][Full Text] [Related]
8. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.
Tolbert D; Cloyd J; Biton V; Bekersky I; Walzer M; Wesche D; Drummond R; Lee D
Epilepsia; 2015 Jun; 56(6):915-23. PubMed ID: 25982590
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
Deleu D; Aarons L; Ahmed IA
Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of carbamazepine in adults with epilepsy.
Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Chan E; Lee HS; Hue SS
Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of carbamazepine in elderly patients.
Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK
Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657
[TBL] [Abstract][Full Text] [Related]
14. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
15. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M
Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M
Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926
[TBL] [Abstract][Full Text] [Related]
17. Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats.
Ren T; Xiao M; Yang M; Zhao J; Zhang Y; Hu M; Cheng Y; Xu H; Zhang C; Yan X; Zuo Z
AAPS J; 2019 Jul; 21(5):90. PubMed ID: 31321577
[TBL] [Abstract][Full Text] [Related]
18. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
[TBL] [Abstract][Full Text] [Related]
19. Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbamazepine-10, 11-epoxide, and 10-hydroxycarbazepine.
Tutor-Crespo MJ; Hermida J; Tutor JC
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):91-4. PubMed ID: 17690747
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
Ahmad A; Garnett WR
Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]